Does AXITINIB Cause Product dose omission issue? 304 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 304 reports of Product dose omission issue have been filed in association with AXITINIB (INLYTA). This represents 1.9% of all adverse event reports for AXITINIB.
304
Reports of Product dose omission issue with AXITINIB
1.9%
of all AXITINIB reports
15
Deaths
62
Hospitalizations
How Dangerous Is Product dose omission issue From AXITINIB?
Of the 304 reports, 15 (4.9%) resulted in death, 62 (20.4%) required hospitalization, and 3 (1.0%) were considered life-threatening.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AXITINIB. However, 304 reports have been filed with the FAERS database.
What Other Side Effects Does AXITINIB Cause?
Death (2,222)
Diarrhoea (2,187)
Fatigue (1,816)
Neoplasm progression (1,315)
Hypertension (1,146)
Off label use (1,075)
Nausea (955)
Decreased appetite (920)
Dysphonia (871)
Disease progression (768)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which AXITINIB Alternatives Have Lower Product dose omission issue Risk?
AXITINIB vs AZACITIDINE
AXITINIB vs AZATHIOPRINE
AXITINIB vs AZD-1222
AXITINIB vs AZELAIC ACID
AXITINIB vs AZELASTINE